Coralmyn

Coralmyn is a drug derived from the venom of the Eastern Diamondback Rattlesnake. It is used as an antivenom for the treatment of bites from the North American Coral Snake.

History

Coralmyn was developed by the Mexican company, Bioclon Institute. The drug was approved by the Food and Drug Administration (FDA) in the United States in 2000.

Mechanism of Action

Coralmyn works by neutralizing the venom of the North American Coral Snake. The venom of this snake is neurotoxic, causing paralysis and potentially death. Coralmyn binds to the venom, preventing it from causing damage to the nervous system.

Side Effects

Like all drugs, Coralmyn can cause side effects. These can include allergic reactions, such as hives, difficulty breathing, and swelling of the face, lips, tongue, or throat. Other side effects can include nausea, vomiting, and diarrhea.

Contraindications

Coralmyn should not be used in people who are allergic to it or to any other antivenom. It should also not be used in people with a history of severe allergic reactions to snake venom.

See Also

• Antivenom
• Eastern Diamondback Rattlesnake
• North American Coral Snake
• Bioclon Institute
• Food and Drug Administration

Coralmyn Resources
Latest articles Most recent articles Ongoing trials	Wikipedia